Where it comes from
- Made in
- Pituitary gonadotrophs, liver, kidney, skin and the ovary
- Sent out by
- Inflammation in the liver; the cycle in the pituitary and ovary
- Acts on
- Pituitary (FSH)
- Hepatocytes (hepcidin)
- Skin and hair follicle
- Islets
What it does
- The pituitary’s own activin, driving FSH from within the gland
- Raised by inflammation, it drives hepcidin in the liver and so locks iron away, which is part of the anaemia of inflammation 1
- Mice lacking its chain fail to fuse their eyelids before birth; the males breed normally, and the females’ young do not survive 2
In medicine
- No medicine of its own. The approved activin traps, luspatercept and sotatercept, catch activin B along with activin A
- Not measured in care: the assays are research ones, and few laboratories run them
Beyond the body’s own use
- Studied as a driver of kidney fibrosis: injured tubular cells make it, and it activates the fibroblasts around them in mice 3
- Studied as a marker in early pregnancy loss. In one case-control series the serum level was lower in tubal ectopic pregnancy than in a normal pregnancy, but it could not separate an ectopic from a miscarriage 4
Sources
- Besson-Fournier et al., Induction of activin B by inflammatory stimuli up-regulates hepcidin, Blood 2012
- Vassalli et al., Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction, Genes and Development 1994
- Sun et al., Tubule-derived INHBB promotes interstitial fibroblast activation and renal fibrosis, Journal of Pathology 2022
- Dhiman et al., Serum activin B concentration as predictive biomarker for ectopic pregnancy, Clinical Biochemistry 2016
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.